欧洲特应性皮炎工作组立场文件:父母特应性皮炎在备孕期、妊娠期和哺乳期的治疗
欧洲特应性皮炎工作组(ETFAD)发布立场文件,针对计划生育、妊娠期及哺乳期特应性皮炎成人患者提出治疗建议。基于最新文献、专家意见及安全性数据,认为外用保湿剂、外用糖皮质激素、他克莫司、抗菌剂及紫外线治疗安全;系统治疗仅限糖皮质激素、环孢素A,特定情况可用硫唑嘌呤。
要点
- 外用保湿剂、外用糖皮质激素、他克莫司、抗菌剂及紫外线治疗在备孕、妊娠和哺乳期被视为安全。
- 系统治疗需谨慎考虑,仅推荐系统糖皮质激素和环孢素A,特定病例可用硫唑嘌呤。
- 现有安全性数据多来自其他炎症性疾病或移植医学,需结合专家意见个体化决策。
核心结论
- ETFAD认为外用治疗(保湿剂、外用糖皮质激素、他克莫司、抗菌剂如氯己定、奥替尼啶、高锰酸钾、次氯酸钠)及紫外线治疗对备孕、妊娠和哺乳期特应性皮炎患者安全。
- 系统治疗应仅在仔细考虑后处方,推荐限于系统糖皮质激素和环孢素A,特定病例可用硫唑嘌呤。
研究设计与样本
- ETFAD立场文件,基于最新科学文献、ETFAD成员专家意见及现有安全性数据制定。
主要发现
- 外用保湿剂、外用糖皮质激素、他克莫司、抗菌剂(氯己定、奥替尼啶、高锰酸钾、次氯酸钠)及紫外线治疗被视为安全。
- 系统治疗仅推荐系统糖皮质激素和环孢素A,特定病例可用硫唑嘌呤。
关键数值与推荐
- 安全的外用治疗包括保湿剂、外用糖皮质激素、他克莫司、抗菌剂(氯己定、奥替尼啶、高锰酸钾、次氯酸钠)及紫外线治疗。
- 系统治疗限于系统糖皮质激素和环孢素A,特定病例可用硫唑嘌呤。
临床怎么用
- 对备孕、妊娠及哺乳期特应性皮炎患者,优先选择外用治疗和紫外线治疗。
- 系统治疗需谨慎评估,仅考虑系统糖皮质激素、环孢素A,特定情况可用硫唑嘌呤。
局限性
- 许多安全性数据来自其他炎症性疾病患者或移植医学,非特应性皮炎人群直接证据有限。
- 建议基于ETFAD专家意见,证据级别可能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Atopic dermatitis (AD) is a common inflammatory skin disease that affects both children and adults, including a large number of adults of reproductive age. Several guidelines for the treatment of AD exist, yet specific recommendations for the treatment of pregnant or lactating women and for adults planning to have a child are often lacking. This position paper from the European Task force on Atopic Dermatitis (ETFAD) is based on up-to-date scientific literature on treating pregnant and lactating women as wells as adults with AD planning to have a child. It is based on the expert opinions of members of the ETFAD and on existing safety data on the proposed treatments, many of which are derived from patients with other inflammatory diseases or from transplantation medicine. For treating future parents, as well as pregnant and lactating women with AD, the use of topical treatments including moisturizers, topical corticosteroids, tacrolimus, antiseptics such as chlorhexidine, octenidine, potassium permanganate and sodium hypochlorite (bleach) is deemed to be safe. Ultraviolet (UV) therapy may also be used. Systemic treatment should be prescribed only after careful consideration. According to the opinion of the ETFAD, treatment should be restricted to systemic corticosteroids and cyclosporine A, and, in selected cases, azathioprine.
引用
- Vestergaard C, Wollenberg A, Barbarot S, et al. European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period. J Eur Acad Dermatol Venereol. 2019. PMID: 31231864. doi:10.1111/jdv.15709
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。